Home / Featured Companies / Biogen Historical Data

Biogen (BIIB) Financials

Biogen (BIIB) Historical Financial Statements and Key Metrics for 1991 - 2021

Full Biogen financials for 1991 - 2021 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Biogen Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2021-Mar-31 2,694 2,216 (82.3 %) 1 (0.0 %) 404 (15.0 %) 147 2.57
2020-Dec-31 2,853 2,362 (82.8 %) -486 (-17.0 %) 358 (12.5 %) -396 2.28
2020-Sep-30 3,376 2,927 (86.7 %) 1,057 (28.4 %) 702 (20.8 %) 1,198 4.46
2020-Jun-30 3,682 3,270 (88.8 %) 1,984 (55.3 %) 1,542 (41.9 %) 2,109 9.59
2020-Mar-31 3,534 3,080 (87.1 %) 1,820 (51.5 %) 1,399 (39.6 %) 1,696 8.08
2019-Dec-31 3,671 3,224 (87.8 %) 1,778 (48.4 %) 1,440 (39.2 %) 1,875 8.08
2019-Sep-30 3,600 3,170 (88.1 %) 1,806 (50.2 %) 1,546 (42.9 %) 2,132 8.39
Full historical income statements for 1991 - 2021 is included in the US Historical Financials dataset.

Biogen Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2021-Mar-31 23,854 13,191 7,267 10,682 2,537
2020-Dec-31 24,619 13,933 8,705 10,700 2,610
2020-Sep-30 24,934 14,190 7,834 10,758 3,580
2020-Jun-30 25,512 14,223 7,839 11,309 4,328
2020-Mar-31 26,119 13,572 5,962 12,547 3,860
2019-Dec-31 27,234 13,891 5,955 13,343 4,476
2019-Sep-30 27,484 13,488 5,954 13,996 4,437
Full historical balance sheet data for 1991 - 2021 is included in the US Historical Financials dataset.

Biogen Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2021-Mar-31 769 -64 -785 677
2020-Dec-31 -367 -166 -401 -468
2020-Sep-30 1,181 0 0 1,097
2020-Jun-30 1,948 0 0 1,844
2020-Mar-31 1,467 443 -2,245 1,206
2019-Dec-31 1,960 708 -2,116 1,695
2019-Sep-30 1,695 -366 -689 1,605
Full historical cash flow data for 1991 - 2021 is included in the US Historical Financials dataset.

Biogen Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2021-Mar-31 43,893 49,943 16.29 27.16 4.11
2020-Dec-31 38,419 44,514 13.47 26.84 3.59
2020-Sep-30 44,509 51,065 13.18 63.45 4.14
2020-Jun-30 42,969 49,950 11.67 27.86 3.80
2020-Mar-31 54,765 58,135 15.50 39.14 4.36
2019-Dec-31 52,877 55,918 14.40 36.73 3.96
2019-Sep-30 42,885 46,495 11.91 27.74 3.06
Full historical valuation and operating metrics for 1991 - 2021 are included in the US Historical Financials dataset.